Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Colgate Total

This article was originally published in The Tan Sheet

Executive Summary

Colgate Total: Recently-approved NDAed dentifrice promoted as "The most advanced toothpaste of our time" and "The greatest advance in toothpaste since fluoride" in literature targeted at professionals. The ads highlight that Total is "The first and only toothpaste in the U.S. proven to help protect against caries, gingivitis and calculus." In the materials, Colgate-Palmolive supports the individual indications with charts based on clinical data. The trade material also emphasizes, "Protection that lasts from brushing to brushing." The promos dramatize the product's claims by placing the tube on a clock face. The material also advertises that Total is the only toothpaste in the U.S. with triclosan. Colgate distributed the materials Oct. 18 during the American Dental Association's annual session in Washington, D.C. Colgate has indicated the product will be supported with an "extremely heavy" ad/promo budget, and sampling to dentists' offices will be a "key" factor in the promo plans. The product's NDA was approved by FDA July 14; Colgate plans to have Total in stores by January ("The Tan Sheet" July 21, p. 1)...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel